Click here to get full coverage on Analysts Express Mixed Opinion on Argenx SE (ARGX) Stock - Yahoo Finance

Analysts Express Mixed Opinion on Argenx SE (ARGX) Stock  Yahoo Finance

Analysts Express Mixed Opinion on Argenx SE (ARGX) Stock - Yahoo Finance

Click here to get full coverage on Wedbush Reiterates Outperform Rating for argenx (ARGX) with $100 - GuruFocus

Wedbush Reiterates Outperform Rating for argenx (ARGX) with $100  GuruFocus

Wedbush Reiterates Outperform Rating for argenx (ARGX) with $100 - GuruFocus

Click here to get full coverage on Forecasting The Future: 16 Analyst Projections For argenx - Benzinga

Forecasting The Future: 16 Analyst Projections For argenx  Benzinga

Forecasting The Future: 16 Analyst Projections For argenx - Benzinga

Click here to get full coverage on Oversold Conditions For argenx (ARGX) - Nasdaq

Oversold Conditions For argenx (ARGX)  Nasdaq

Oversold Conditions For argenx (ARGX) - Nasdaq

Click here to get full coverage on New argenx data show potential first targeted treatment for ocular MG - Stock Titan

New argenx data show potential first targeted treatment for ocular MG  Stock Titan

New argenx data show potential first targeted treatment for ocular MG - Stock Titan

Click here to get full coverage on Price-Driven Insight from (ARGX) for Rule-Based Strategy - Stock Traders Daily

Price-Driven Insight from (ARGX) for Rule-Based Strategy  Stock Traders Daily

Price-Driven Insight from (ARGX) for Rule-Based Strategy - Stock Traders Daily

Click here to get full coverage on Argenx Opens Phase 1 Safety Trial for ARGX-124, Expanding Its Pipeline Potential - TipRanks

Argenx Opens Phase 1 Safety Trial for ARGX-124, Expanding Its Pipeline Potential  TipRanks

Argenx Opens Phase 1 Safety Trial for ARGX-124, Expanding Its Pipeline Potential - TipRanks

Click here to get full coverage on Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting - The Globe and Mail

Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting  The Globe and Mail

Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting - The Globe and Mail

Click here to get full coverage on ARGX: Growth-focused strategy leverages innovation, pipeline expansion, and leadership in FcRn and MG - TradingView

ARGX: Growth-focused strategy leverages innovation, pipeline expansion, and leadership in FcRn and MG  TradingView

ARGX: Growth-focused strategy leverages innovation, pipeline expansion, and leadership in FcRn and MG - TradingView

Click here to get full coverage on KMDA vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

KMDA vs. ARGX: Which Stock Is the Better Value Option?  Yahoo Finance

KMDA vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on Artisan Mid Cap Fund Maintains Its Confidence in Argenx’s (ARGX) VYVGART - Yahoo Finance

Artisan Mid Cap Fund Maintains Its Confidence in Argenx’s (ARGX) VYVGART  Yahoo Finance

Artisan Mid Cap Fund Maintains Its Confidence in Argenx’s (ARGX) VYVGART - Yahoo Finance

Click here to get full coverage on Why Argenx SE (ARGX) Stock Advanced on Commercial Execution - Yahoo Finance

Why Argenx SE (ARGX) Stock Advanced on Commercial Execution  Yahoo Finance

Why Argenx SE (ARGX) Stock Advanced on Commercial Execution - Yahoo Finance

Click here to get full coverage on argenx SE (ARGX): A Bull Case Theory - Yahoo Finance

argenx SE (ARGX): A Bull Case Theory  Yahoo Finance

argenx SE (ARGX): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Citi Remains Bullish on Argenx SE (ARGX) - Yahoo Finance

Citi Remains Bullish on Argenx SE (ARGX)  Yahoo Finance

Citi Remains Bullish on Argenx SE (ARGX) - Yahoo Finance

Click here to get full coverage on Argenx’s (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments - Yahoo Finance

Argenx’s (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments  Yahoo Finance

Argenx’s (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments - Yahoo Finance

Click here to get full coverage on Analysts May Have Underestimated Argenx SE’s (ARGX) 5 year Revenue Growth - Yahoo Finance

Analysts May Have Underestimated Argenx SE’s (ARGX) 5 year Revenue Growth  Yahoo Finance

Analysts May Have Underestimated Argenx SE’s (ARGX) 5 year Revenue Growth - Yahoo Finance

Click here to get full coverage on Eye muscle disease trial finds VYVGART eases double vision in MG - Stock Titan

Eye muscle disease trial finds VYVGART eases double vision in MG  Stock Titan

Eye muscle disease trial finds VYVGART eases double vision in MG - Stock Titan

Click here to get full coverage on HRMY vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

HRMY vs. ARGX: Which Stock Is the Better Value Option?  Yahoo Finance

HRMY vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on Increased Demand for Vyvgart Boosted Argenx SE (ARGX) in Q4 - Yahoo Finance

Increased Demand for Vyvgart Boosted Argenx SE (ARGX) in Q4  Yahoo Finance

Increased Demand for Vyvgart Boosted Argenx SE (ARGX) in Q4 - Yahoo Finance

Click here to get full coverage on Here’s Why argenx SE (ARGX) Rose in Q3 - Yahoo Finance

Here’s Why argenx SE (ARGX) Rose in Q3  Yahoo Finance

Here’s Why argenx SE (ARGX) Rose in Q3 - Yahoo Finance

Click here to get full coverage on Fund Update: New $28.5M $ARGX stock position opened by VICTORY CAPITAL MANAGEMENT INC - Quiver Quantitative

Fund Update: New $28.5M $ARGX stock position opened by VICTORY CAPITAL MANAGEMENT INC  Quiver Quantitative

Fund Update: New $28.5M $ARGX stock position opened by VICTORY CAPITAL MANAGEMENT INC - Quiver Quantitative

Click here to get full coverage on Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone - Yahoo Finance

Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone  Yahoo Finance

Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone - Yahoo Finance

Click here to get full coverage on Maintained Buy by BofA on ARGX argenx SE Feb 2026 - Meyka

Maintained Buy by BofA on ARGX argenx SE Feb 2026  Meyka

Maintained Buy by BofA on ARGX argenx SE Feb 2026 - Meyka

Click here to get full coverage on argenx SE (ARGX) Reports Q4 Earnings Beat Amid Revenue Miss - GuruFocus

argenx SE (ARGX) Reports Q4 Earnings Beat Amid Revenue Miss  GuruFocus

argenx SE (ARGX) Reports Q4 Earnings Beat Amid Revenue Miss - GuruFocus

Click here to get full coverage on argenex (NASDAQ:ARGX) Issues Quarterly Earnings Results - MarketBeat

argenex (NASDAQ:ARGX) Issues Quarterly Earnings Results  MarketBeat

argenex (NASDAQ:ARGX) Issues Quarterly Earnings Results - MarketBeat

Click here to get full coverage on ARGX Stock Rating Update: Citizens Raises Price Target to $944 | - GuruFocus

ARGX Stock Rating Update: Citizens Raises Price Target to $944 |  GuruFocus

ARGX Stock Rating Update: Citizens Raises Price Target to $944 | - GuruFocus

Click here to get full coverage on ARGX: Guggenheim Lowers Price Target While Maintaining 'Buy' Rat - GuruFocus

ARGX: Guggenheim Lowers Price Target While Maintaining 'Buy' Rat  GuruFocus

ARGX: Guggenheim Lowers Price Target While Maintaining 'Buy' Rat - GuruFocus

Click here to get full coverage on Wells Fargo Lowers Price Target for argenx (ARGX) but Maintains Overweight Rating | ARGX Stock News - GuruFocus

Wells Fargo Lowers Price Target for argenx (ARGX) but Maintains Overweight Rating | ARGX Stock News  GuruFocus

Wells Fargo Lowers Price Target for argenx (ARGX) but Maintains Overweight Rating | ARGX Stock News - GuruFocus

Click here to get full coverage on Assessing argenx (ENXTBR:ARGX) Valuation After Recent Share Price Pullback - Yahoo Finance

Assessing argenx (ENXTBR:ARGX) Valuation After Recent Share Price Pullback  Yahoo Finance

Assessing argenx (ENXTBR:ARGX) Valuation After Recent Share Price Pullback - Yahoo Finance

Click here to get full coverage on Wells Fargo Analyst Sees Potential in Argenx SE’s (ARGX) Vyvgart, Increases PT to $1,317 - Yahoo Finance

Wells Fargo Analyst Sees Potential in Argenx SE’s (ARGX) Vyvgart, Increases PT to $1,317  Yahoo Finance

Wells Fargo Analyst Sees Potential in Argenx SE’s (ARGX) Vyvgart, Increases PT to $1,317 - Yahoo Finance

Click here to get full coverage on Is It Time To Revisit argenx (ENXTBR:ARGX) After Recent Share Price Weakness - Yahoo Finance

Is It Time To Revisit argenx (ENXTBR:ARGX) After Recent Share Price Weakness  Yahoo Finance

Is It Time To Revisit argenx (ENXTBR:ARGX) After Recent Share Price Weakness - Yahoo Finance

Click here to get full coverage on Argenx (ARGX) Surpasses Revenue Expectations with Strong 2025 Pe - GuruFocus

Argenx (ARGX) Surpasses Revenue Expectations with Strong 2025 Pe  GuruFocus

Argenx (ARGX) Surpasses Revenue Expectations with Strong 2025 Pe - GuruFocus

Click here to get full coverage on argenx (ENXTBR:ARGX) Earnings Beat Growth Expectations, Reinforcing Bull Case on Margins and Valuation - Yahoo Finance

argenx (ENXTBR:ARGX) Earnings Beat Growth Expectations, Reinforcing Bull Case on Margins and Valuation  Yahoo Finance

argenx (ENXTBR:ARGX) Earnings Beat Growth Expectations, Reinforcing Bull Case on Margins and Valuation - Yahoo Finance

Click here to get full coverage on Evaluating argenx (ENXTBR:ARGX): Does Market Momentum Reflect True Valuation? - Yahoo Finance

Evaluating argenx (ENXTBR:ARGX): Does Market Momentum Reflect True Valuation?  Yahoo Finance

Evaluating argenx (ENXTBR:ARGX): Does Market Momentum Reflect True Valuation? - Yahoo Finance

Click here to get full coverage on Should You be Confident in Argenx SE (ARGX)? - Yahoo Finance

Should You be Confident in Argenx SE (ARGX)?  Yahoo Finance

Should You be Confident in Argenx SE (ARGX)? - Yahoo Finance

Click here to get full coverage on argenx: Sights Set On $1,000 (NASDAQ:ARGX) - Seeking Alpha

argenx: Sights Set On $1,000 (NASDAQ:ARGX)  Seeking Alpha

argenx: Sights Set On $1,000 (NASDAQ:ARGX) - Seeking Alpha

Click here to get full coverage on (ARGX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

(ARGX) Price Dynamics and Execution-Aware Positioning  Stock Traders Daily

(ARGX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Click here to get full coverage on Should You Be Confident in Argenx SE’ (ARGX) Long-Term Profit Cycle? - Yahoo Finance

Should You Be Confident in Argenx SE’ (ARGX) Long-Term Profit Cycle?  Yahoo Finance

Should You Be Confident in Argenx SE’ (ARGX) Long-Term Profit Cycle? - Yahoo Finance

Click here to get full coverage on A Look At argenx (ENXTBR:ARGX) Valuation After Recent Share Price Weakness - Yahoo Finance

A Look At argenx (ENXTBR:ARGX) Valuation After Recent Share Price Weakness  Yahoo Finance

A Look At argenx (ENXTBR:ARGX) Valuation After Recent Share Price Weakness - Yahoo Finance

Click here to get full coverage on How Investors Are Reacting To argenx (ENXTBR:ARGX) Leadership Shift And Expanding Immunology Pipeline - Yahoo Finance

How Investors Are Reacting To argenx (ENXTBR:ARGX) Leadership Shift And Expanding Immunology Pipeline  Yahoo Finance

How Investors Are Reacting To argenx (ENXTBR:ARGX) Leadership Shift And Expanding Immunology Pipeline - Yahoo Finance

Click here to get full coverage on argenx (NASDAQ: ARGX) halts UplighTED TED studies, sees favorable safety - Stock Titan

argenx (NASDAQ: ARGX) halts UplighTED TED studies, sees favorable safety  Stock Titan

argenx (NASDAQ: ARGX) halts UplighTED TED studies, sees favorable safety - Stock Titan

Click here to get full coverage on argenex (ARGX) Expected to Announce Earnings on Thursday - MarketBeat

argenex (ARGX) Expected to Announce Earnings on Thursday  MarketBeat

argenex (ARGX) Expected to Announce Earnings on Thursday - MarketBeat

Click here to get full coverage on What To Expect From argenx SE (XBRU:ARGX) Q4 2025 Earnings - GuruFocus

What To Expect From argenx SE (XBRU:ARGX) Q4 2025 Earnings  GuruFocus

What To Expect From argenx SE (XBRU:ARGX) Q4 2025 Earnings - GuruFocus

Click here to get full coverage on argenx SE (ARGX) Expands Autoimmune Leadership with Vyvgart Launch - Yahoo Finance

argenx SE (ARGX) Expands Autoimmune Leadership with Vyvgart Launch  Yahoo Finance

argenx SE (ARGX) Expands Autoimmune Leadership with Vyvgart Launch - Yahoo Finance

Click here to get full coverage on argenx (NASDAQ: ARGX) 95.67% approval of remuneration policy, 91.1% capital present - Stock Titan

argenx (NASDAQ: ARGX) 95.67% approval of remuneration policy, 91.1% capital present  Stock Titan

argenx (NASDAQ: ARGX) 95.67% approval of remuneration policy, 91.1% capital present - Stock Titan

Click here to get full coverage on Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability - FinancialContent

Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability  FinancialContent

Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability - FinancialContent

Click here to get full coverage on Here’s What Pulled Down Argenx (ARGX) in Q2 - Yahoo Finance

Here’s What Pulled Down Argenx (ARGX) in Q2  Yahoo Finance

Here’s What Pulled Down Argenx (ARGX) in Q2 - Yahoo Finance

Click here to get full coverage on How Investors May Respond To argenx (ENXTBR:ARGX) Halting Thyroid Eye Disease Efgartigimod Trials - Yahoo Finance

How Investors May Respond To argenx (ENXTBR:ARGX) Halting Thyroid Eye Disease Efgartigimod Trials  Yahoo Finance

How Investors May Respond To argenx (ENXTBR:ARGX) Halting Thyroid Eye Disease Efgartigimod Trials - Yahoo Finance

Click here to get full coverage on Argenx Se (ARGX) Gets a Buy from Goldman Sachs - The Globe and Mail

Argenx Se (ARGX) Gets a Buy from Goldman Sachs  The Globe and Mail

Argenx Se (ARGX) Gets a Buy from Goldman Sachs - The Globe and Mail

Click here to get full coverage on KROS vs. ARGX: Which Stock Is the Better Value Option? - Nasdaq

KROS vs. ARGX: Which Stock Is the Better Value Option?  Nasdaq

KROS vs. ARGX: Which Stock Is the Better Value Option? - Nasdaq

Click here to get full coverage on argenx SE (ARGX) Rose due to Increased Sales of its Vyvgart Medication - Yahoo Finance

argenx SE (ARGX) Rose due to Increased Sales of its Vyvgart Medication  Yahoo Finance

argenx SE (ARGX) Rose due to Increased Sales of its Vyvgart Medication - Yahoo Finance

Click here to get full coverage on Oppenheimer Reaffirms Its Outperform Rating on argenx SE (ARGX) - Yahoo Finance

Oppenheimer Reaffirms Its Outperform Rating on argenx SE (ARGX)  Yahoo Finance

Oppenheimer Reaffirms Its Outperform Rating on argenx SE (ARGX) - Yahoo Finance

Click here to get full coverage on HRMY or ARGX: Which Is the Better Value Stock Right Now? - Yahoo Finance

HRMY or ARGX: Which Is the Better Value Stock Right Now?  Yahoo Finance

HRMY or ARGX: Which Is the Better Value Stock Right Now? - Yahoo Finance

Click here to get full coverage on Insights into argenx's Upcoming Earnings - Benzinga

Insights into argenx's Upcoming Earnings  Benzinga

Insights into argenx's Upcoming Earnings - Benzinga

Click here to get full coverage on Patient Square Capital LP Sells 13,500 Shares of argenex SE $ARGX - MarketBeat

Patient Square Capital LP Sells 13,500 Shares of argenex SE $ARGX  MarketBeat

Patient Square Capital LP Sells 13,500 Shares of argenex SE $ARGX - MarketBeat

Click here to get full coverage on Optiver Holding B.V. Trims Stock Position in argenex SE $ARGX - MarketBeat

Optiver Holding B.V. Trims Stock Position in argenex SE $ARGX  MarketBeat

Optiver Holding B.V. Trims Stock Position in argenex SE $ARGX - MarketBeat

Click here to get full coverage on Is It Time To Revisit argenx (ENXTBR:ARGX) After Recent Share Price Weakness? - simplywall.st

Is It Time To Revisit argenx (ENXTBR:ARGX) After Recent Share Price Weakness?  simplywall.st

Is It Time To Revisit argenx (ENXTBR:ARGX) After Recent Share Price Weakness? - simplywall.st

Click here to get full coverage on Argenx (ENXTBR:ARGX) Margin Compression Challenges Bullish Earnings Growth Narrative - simplywall.st

Argenx (ENXTBR:ARGX) Margin Compression Challenges Bullish Earnings Growth Narrative  simplywall.st

Argenx (ENXTBR:ARGX) Margin Compression Challenges Bullish Earnings Growth Narrative - simplywall.st

Click here to get full coverage on Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting - TipRanks

Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting  TipRanks

Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting - TipRanks

Click here to get full coverage on These Analysts Revise Their Forecasts On Argenx After Q4 Earnings - Benzinga

These Analysts Revise Their Forecasts On Argenx After Q4 Earnings  Benzinga

These Analysts Revise Their Forecasts On Argenx After Q4 Earnings - Benzinga

Click here to get full coverage on A Look At argenx (ENXTBR:ARGX) Valuation After Mixed Recent Share Performance - simplywall.st

A Look At argenx (ENXTBR:ARGX) Valuation After Mixed Recent Share Performance  simplywall.st

A Look At argenx (ENXTBR:ARGX) Valuation After Mixed Recent Share Performance - simplywall.st

Click here to get full coverage on New Analyst Forecast: $ARGX Given $1248 Price Target - Quiver Quantitative

New Analyst Forecast: $ARGX Given $1248 Price Target  Quiver Quantitative

New Analyst Forecast: $ARGX Given $1248 Price Target - Quiver Quantitative

Click here to get full coverage on KROS vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

KROS vs. ARGX: Which Stock Is the Better Value Option?  Yahoo Finance

KROS vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on Why (ARGX) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Why (ARGX) Price Action Is Critical for Tactical Trading  Stock Traders Daily

Why (ARGX) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Click here to get full coverage on argenx (NASDAQ: ARGX) sets financial results call for October 30, 2025 with replay - Stock Titan

argenx (NASDAQ: ARGX) sets financial results call for October 30, 2025 with replay  Stock Titan

argenx (NASDAQ: ARGX) sets financial results call for October 30, 2025 with replay - Stock Titan

Click here to get full coverage on (ARGX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

(ARGX) as a Liquidity Pulse for Institutional Tactics  Stock Traders Daily

(ARGX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Click here to get full coverage on TimesSquare Capital Management LLC Sells 6,050 Shares of argenex SE $ARGX - MarketBeat

TimesSquare Capital Management LLC Sells 6,050 Shares of argenex SE $ARGX  MarketBeat

ARGX

Price Chart

Key Statistics

Technicals

About ARGX

Latest News

Analysts Express Mixed Opinion on Argenx SE (ARGX) Stock - Yahoo Finance

Wedbush Reiterates Outperform Rating for argenx (ARGX) with $100 - GuruFocus

Forecasting The Future: 16 Analyst Projections For argenx - Benzinga

Advanced Charts

Top Gainers

Top Losers